Search research articles
Contact Us
Filters
Showing results (41-50 of 43) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 43 results.
Clinical Pharmacology and Therapeutics
|
September 24, 2019
Development of a Disease Progression Model for Leucine-Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial Designs
Malidi Ahamadi, Daniela J Conrado, Sreeraj Macha, et al.
Journal of Medicinal Chemistry
|
December 10, 2016
Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)-A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer's Disease
Jack D Scott, Sarah W Li, Andrew P J Brunskill, et al.
The American Journal of Gastroenterology
|
April 20, 2022
Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease: A Series of N-of-1 Diet Trials
Heather C Kaplan, Lisa Opipari-Arrigan, Jiabei Yang, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 43) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 43 results.
Clinical Pharmacology and Therapeutics
|
September 24, 2019
Development of a Disease Progression Model for Leucine-Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial Designs
Malidi Ahamadi, Daniela J Conrado, Sreeraj Macha, et al.
Journal of Medicinal Chemistry
|
December 10, 2016
Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)-A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer's Disease
Jack D Scott, Sarah W Li, Andrew P J Brunskill, et al.
The American Journal of Gastroenterology
|
April 20, 2022
Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease: A Series of N-of-1 Diet Trials
Heather C Kaplan, Lisa Opipari-Arrigan, Jiabei Yang, et al.
Page
of 5